Memorandum

Second Sight Medical Products Announces a New NIH Grant Supplement for Its Orion Study

Retrieved on: 
Wednesday, August 11, 2021

The entirety of the $155,964 grant supplement will be provided to UCLA as a subcontractor to conduct the study.

Key Points: 
  • The entirety of the $155,964 grant supplement will be provided to UCLA as a subcontractor to conduct the study.
  • The grant supplement is related to the $6.4 million NIH grant for the Early Feasibility Clinical Trial of a Visual Cortical Prosthesis, grant UH3NS103442.
  • Second Sight reported promising two-year data from the Orion trial on May 12, 2021.
  • About Second Sight Medical Products, Inc.
    Second Sight Medical Products, Inc. (Nasdaq: EYES) develops implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals.

Publication of Prospectus Supplement

Retrieved on: 
Wednesday, May 12, 2021

b'Other content available on Shell\xe2\x80\x99s website and the content of any other website accessible from hyperlinks on Shell\xe2\x80\x99s website is not incorporated into, and does not form part of, this announcement.\nThe Documents will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationa lstoragemechanism.\nThe Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • b'Other content available on Shell\xe2\x80\x99s website and the content of any other website accessible from hyperlinks on Shell\xe2\x80\x99s website is not incorporated into, and does not form part of, this announcement.\nThe Documents will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationa lstoragemechanism.\nThe Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.\nPlease note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.\nYour right to access this service is conditional upon complying with the above requirement.\n'

Publication of Prospectus Supplement

Retrieved on: 
Friday, March 26, 2021

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Publication of Prospectus Supplement

Retrieved on: 
Tuesday, November 3, 2020

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Tenet Announces $2.5 Billion Private Offering of Senior Notes

Retrieved on: 
Tuesday, September 1, 2020

Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $2.5 billion in aggregate principal amount of newly issued senior notes maturing in 2028 (the notes).

Key Points: 
  • Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $2.5 billion in aggregate principal amount of newly issued senior notes maturing in 2028 (the notes).
  • Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance, together with cash on hand, the redemption of all of its outstanding 8.125% Senior Notes due 2022.
  • A confidential offering memorandum for the notes will be made available to such eligible persons.
  • The offering will be conducted in accordance with the terms and subject to the conditions set forth in such offering memorandum.

Publication of Prospectus

Retrieved on: 
Monday, August 17, 2020

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Publication of Prospectus Supplement

Retrieved on: 
Friday, May 1, 2020

The Documents have also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Key Points: 
  • The Documents have also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Publication of Prospectus Supplement

Retrieved on: 
Wednesday, April 1, 2020

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Publication of Prospectus Supplement

Retrieved on: 
Friday, March 20, 2020

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.

Publication of Prospectus Supplement

Retrieved on: 
Friday, February 7, 2020

The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.

Key Points: 
  • The Information Memorandum is not provided for, or directed at, U.S. persons or persons in the United States.
  • If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.
  • Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed.
  • Prior to relying on the information contained in the Information Memorandum, you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.